ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,022.21
      -0.58%
      US Tech 100
      17,063.60
      -1.05%
      Dow Jones
      37,753.31
      -0.12%
      Brent Oil
      86.915
      -0.08%
      Bitcoin
      60,982.42
      -0.48%
      Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Precipio Inc (PRPO)

      7. Precipio Inc (PRPO) News

      PRPO Precipio Inc

      6.705
      -0.0305 (-0.45%)
      Apr 17 2024 - Closed
      Delayed by 15 minutes
      Company Name Stock Ticker Symbol Market Type
      Precipio Inc PRPO NASDAQ Common Stock
        Price Change Change Percent Stock Price Last Traded
      Upgrade Icon
      -0.0305 -0.45% 6.705 20:00:00
      Open Price Low Price High Price Close Price Prev Close
      6.75 6.60 6.75 6.705 6.7355
      more quote information »

      Recent News

      Date Time Source Heading
      4/17/20248:00IHNWFeaturedGlucotrack Announces Expansion of Its Continuous Glucose Monitoring Technology to Epidural Glucose Monitoring
      3/25/202417:00GLOBEPrecipio Announces Year end 2023 Shareholder Update Call
      2/13/202410:00GLOBEPrecipio to Report $15.2M for FY-2023 (unaudited) Revenues,..
      2/06/202410:00GLOBEPrecipio and Cardinal Health Sign Distribution Agreement for..
      1/23/202410:00GLOBEPrecipio’s Q4-2023 Cash Burn From Operations (unaudited)..
      1/19/202416:05EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
      1/17/202410:30GLOBEPrecipio Signs Distribution Agreement For IV-Cell® and..
      1/04/202416:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      1/04/202416:30EDGAR2Form 3 - Initial statement of beneficial ownership of..
      1/02/202417:01EDGAR2Form 8-K - Current report
      1/02/202409:00GLOBEPrecipio Announces Christina Valauri joins the Board of..
      12/14/202317:00EDGAR2Form 8-K - Current report
      12/14/202316:30GLOBEPrecipio Management Shares Thoughts on 2023, and Looks Ahead..
      11/16/202317:15EDGAR2Form 8-K - Current report
      11/16/202317:00GLOBEPrecipio Announces Q3-2023 Shareholder Update Call
      11/13/202316:03EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
      10/31/202316:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      10/26/202316:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      10/26/202316:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      10/26/202316:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      10/18/202309:00GLOBEPrecipio to Report $4.5M Q3-2023 Revenues, Double From..
      10/06/202316:34EDGAR2Form 8-K - Current report
      10/03/202310:00GLOBEPrecipio’s Q3 Cash Burn From Operations (unaudited) Declines..
      9/28/202309:00GLOBEPrecipio Continues to Sign New HemeScreen™ Customers
      9/25/202311:00GLOBEPrecipio Reduces Product Revenue Result Needed for Cash Flow..
      9/21/202317:10EDGAR2Form 8-K - Current report
      9/14/202316:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      9/14/202316:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      9/14/202316:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      9/14/202316:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      9/14/202316:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      9/14/202316:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      9/13/202309:30GLOBEPrecipio’s Pathology Division Exceeds Breakeven Revenues in..
      8/14/202316:00EDGAR2Form 8-K - Current report
      8/11/202316:31EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
      8/10/202317:00GLOBEPrecipio Announces Q2-2023 Shareholder Update Call
      8/08/202309:00GLOBEPrecipio Launches Its Much-Anticipated Quantitative BCR-ABL..
      8/03/202309:00GLOBEPrecipio’s Operational Efficiency Measures Continue To..
      8/01/202309:00GLOBEPrecipio Unaudited Q2-2023 Revenues Show combined increase..
      7/07/202316:30EDGAR2Form S-1 - General form for registration of securities under..
      6/14/202309:49GLOBEPrecipio’s Omnia™ Methodology Enables Diagnosis of MDS With..
      6/13/202309:00GLOBEPrecipio Enters into Collaboration with Prestigious New..
      6/08/202308:30GLOBEPrecipio, Inc. Announces Pricing of $2 Million Registered..
      6/07/202309:30GLOBEProjected cash burn reduced by $1.5 million annually from..
      5/22/202311:00GLOBEPrecipio’s Lab Detects BCR-ABL1 Oncogene Co-Expression of..
      5/17/202316:00GLOBEPrecipio Shares Growth Catalysts For HemeScreen
      5/15/202316:00GLOBEPrecipio Announces Q1-2023 Shareholder Update Call
      5/04/202313:00GLOBEPrecipio Adds Substantial Pathology Customer to its..
      5/04/202310:00GLOBEPrecipio Signs Another HemeScreen™ Customer
      4/27/202317:00GLOBEPrecipio Granted 180-day Extension From NASDAQ To Regain..
      4/19/202311:00GLOBEPrecipio Unaudited Q1-2023 Product Revenues Exceed The Two..

      Your Recent History

      NASDAQ
      PRPO
      Precipio
      Delayed Upgrade Clock